QTTB Q4 2022 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$802,000+0.0% YoY

Gross Profit

$169,00021.1% margin

Operating Income

-$34M-4301.0% margin

Net Income

-$34M-4276.2% margin

EPS (Diluted)

$-10.74

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$10M

Stock-Based Comp.

$318,000

Balance Sheet

Total Assets

$228M

Total Liabilities

$50M

Stockholders' Equity

$178M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$802,000	$802,000	+0.0%
Gross Profit	$169,000	-$2M	+110.6%
Operating Income	-$34M	-$34M	-2.6%
Net Income	-$34M	-$34M	-2.1%